New test identifies people at higher risk of glaucoma, the leading cause of irreversible blindness

Researchers have developed a new genetic test that identifies individuals at a significantly higher risk of developing open-angle glaucoma. By utilizing a polygenic risk score, the test offers improved predictive accuracy for early detection and treatment.
Why it matters
Glaucoma is a leading cause of irreversible blindness, and early detection is critical for preventing vision loss.
by QIMR Berghofer Medical Research Institute
edited by Lisa Lock , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Engin Akyurt from Pexels A new genetic test developed by researchers at QIMR Berghofer and Flinders University, along with international collaborators, can identify people at up to 10 times the normal risk of developing open-angle glaucoma, the most common form of the disease and the leading cause of irreversible blindness worldwide.
The findings, published in Ophthalmology , show the test is a major improvement on earlier versions and could help doctors detect and treat glaucoma before sight is lost.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in